Emran Askari

Nuclear Medicine Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.

[ 1 ] - A report on “the first Concept Map Design Contest on Infection Prevention and Control”

Background Concept maps are considered not only as a powerful method of meaningful learning, but also as an instrument for evaluating the efficiency of learning. Different inquiries suggest that concept maps by promoting critical thinking and clinical reasoning may play a significant role in increasing adherence to infection prevention methods and therefore reduce healthcare-associated infectio...

[ 2 ] - Survey on Etiology of Stevens-Johnson syndrome and Toxic Epidermal Necrolysis in Pediatric Patients: A Six-Year Study from Iran

Background Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are among the most severe dermatologic reactions to the drugs. Data about SJS and TEN among pediatric population especially in Iran is limited. This study aimed to investigate the clinical and para-clinical characteristics of pediatric patients with SJS/TEN. Materials and Methods From 2010 to 2016, all SJS and TEN c...

[ 3 ] - Parotid metastasis as the first presentation of papillary thyroid carcinoma

Parotid metastasis originated from papillary thyroid carcinoma is extremely rare, especially as the first presentation of the disease. We present a 70-year-old man with a history of painless swelling in the right side of the neck. He was evaluated for parotid tumor and histopathologic examination revealed a poorly differentiated carcinoma in the parotid gland with suspicion of thyroid origin. T...

[ 4 ] - [68Ga]Ga-PSMA-11 PET/CT for staging and patient management of high-risk prostate cancer: A single-center experience from Iran

Introduction: Accurate staging plays an important role in management of patients with prostate cancer especially in high-risk group. Today, [68Ga]Ga-PSMA-11 PET/CT should be considered as the preferred imaging tool for treatment planning and initial staging of the disease. Methods: A total number of 628 patients with prostate cancer referred to...